All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemia.
Year: 1995
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: A Venditti, R Stasi, G Del Poeta, F Buccisano, G Aronica, A Bruno, F Pisani, T Caravita, M Masi, M Tribalto
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2340932858
